第 9 節 抗癌瘤藥物
Antineoplastics drugs
- 9.1Aromatase Inhibitors
- 9.2Carboplatin如 Paraplatin、Carboplatin inj115/8/1
- 9.3Docetaxel115/8/1
- 9.4Gemcitabine如 Gemzar115/9/1
- 9.5Paclitaxel成分劑115/8/1
- 9.6Streptococcus pyrogene如 Picibanil
- 9.7（刪除）109/10/1
- 9.8Toremifene如 Fareston88/6/1
- 9.9Vinorelbine106/11/1
- 9.10Oxaliplatin115/2/1
- 9.11Uracil-Tegafur如 Ufur100/1/1
- 9.12Irinotecan114/12/1
- 9.13Aldesleukin如 Proleukin for Injection93/8/1
- 9.14Doxorubicin hydrochloride liposome injection如 Lipo-Dox、Caelyx99/10/1
- 9.15Tretinoin如 Vesanoid Soft Gelatin88/10/1
- 9.16Topotecan如 Hycamtin100/6/1
- 9.17Capecitabine如 Xeloda115/2/1
- 9.18Trastuzumab如 Herceptin115/8/1
- 9.19Estramustine sod. phosphate monohydrate如 Estracyt91/4/1
- 9.20Rituximab注射劑如 Mabthera115/9/1
- 9.21Fludarabine如 Fludara Oral、Film-Coated Tablet及Fludara Lyophilized IV Injection106/11/1
- 9.22Imatinib如 Glivec113/6/1
- 9.23Arsenic trioxide如 Asadin Inj.92/9/1
- 9.24Gefitinib如 Iressa115/8/1
- 9.25Temozolomide如 Temodal111/9/1
- 9.26Pemetrexed如 Alimta115/8/1
- 9.27Cetuximab如 Erbitux115/5/1
- 9.28Bortezomib如 Velcade112/4/1
- 9.29Erlotinib如 Tarceva115/8/1
- 9.30Dasatinib如 Sprycel115/2/1
- 9.31Sunitinib如 Sutent112/3/1
- 9.32Nilotinib115/2/1
- 9.33Thalidomide如 Thado98/7/1
- 9.34Sorafenib如 Nexavar114/6/1
- 9.35carmustine植入劑如 Gliadel Wafer100/2/1
- 9.36Everolimus102/1/1
- 9.37Bevacizumab如 Avastin114/10/1
- 9.38Temsirolimus如 Torisel101/1/1
- 9.39Flutamide；buserelin101/7/1
- 9.40Bicalutamide101/7/1
- 9.41Pazopanib如 Votrient112/10/1
- 9.42Bendamustine如 Innomustine113/2/1
- 9.43Lenalidomide如 Revlimid115/9/1
- 9.44Azacitidine114/12/1
- 9.45Afatinib如 Giotrif115/8/1
- 9.46Tegafur/gimeracil/oteracil複方製劑如 TS-1113/2/1
- 9.47Lapatinib如 Tykerb114/2/1
- 9.48Eribulin如 Halaven110/2/1
- 9.49Abiraterone如 Zytiga114/6/1
- 9.50Crizotinib如 Xalkori113/9/1
- 9.51Regorafenib如 Stivarga113/6/1
- 9.52Vemurafenib如 Zelboraf113/6/1
- 9.53Panitumumab如 Vectibix115/2/1
- 9.54Enzalutamide如 Xtandi114/10/1
- 9.55Ruxolitinib如 Jakavi114/10/1
- 9.56Brentuximab vedotin如 Adcetris114/12/1
- 9.57Clofarabine如 Evoltra109/12/1
- 9.58Axitinib如 Inlyta108/12/1
- 9.59Ceritinib如 Zykadia113/6/1
- 9.60Alectinib如 Alecensa113/6/1
- 9.61Ibrutinib如 Imbruvica115/5/1
- 9.62Pomalidomide如 Pomalyst113/9/1
- 9.63Lenvatinib如 Lenvima114/6/1
- 9.64Blinatumomab如 Blincyto112/12/1
- 9.65Pralatrexate如 Folotyn110/5/1
- 9.66Trifluridine/tipiracil如 Lonsurf115/6/1
- 9.67Ponatinib如 Iclusig115/2/1
- 9.68Radium-223如 Xofigo108/3/1
- 9.69免疫檢查點抑制劑如 atezolizumab、nivolumab、pembrolizumab、avelumab、ipilimumab、durvalumab、tremelimumab、cemiplimab製劑、dostarlimab製劑115/8/1
- 9.70Pertuzumab如 Perjeta114/12/1
- 9.71Venetoclax如 Venclexta114/10/1
- 9.72CDK4/6抑制劑如 ribociclib、palbociclib115/1/1
- 9.73Inotuzumab ozogamicin如 Besponsa112/12/1
- 9.74Cabozantinib如 Cabometyx114/8/1
- 9.75Carfilzomib如 Kyprolis113/4/1
- 9.76Midostaurin如 Rydapt114/10/1
- 9.77Ixazomib如 Ninlaro112/4/1
- 9.78Daratumumab如 Darzalex靜脈注射劑與皮下注射劑114/9/1
- 9.79Obinutuzumab如 Gazyva114/8/1
- 9.80Osimertinib如 Tagrisso115/8/1
- 9.81Lorlatinib如 Lorviqua113/6/1
- 9.82Brigatinib如 Alunbrig113/6/1
- 9.83Dacomitinib如 Vizimpro115/8/1
- 9.84Copanlisib如 Aliqopa113/6/1
- 9.85PARP抑制劑如 olaparib、niraparib、talazoparib114/10/1
- 9.86Vandetanib如 Caprelsa109/11/1
- 9.87Trastuzumab emtansine如 Kadcyla114/5/1
- 9.88Ixabepilone如 Ixempra110/2/1
- 9.89(刪除)112/1/1
- 9.90Apalutamide如 Erleada114/6/1
- 9.91Dabrafenib如 Tafinlar、Mekinist113/6/1
- 9.92Ramucirumab如 Cyramza110/5/1
- 9.93Entrectinib如 Rozlytrek113/6/1
- 9.94Darolutamide如 Nubeqa115/4/1
- 9.95Larotrectinib如 Vitrakvi113/6/1
- 9.96Decitabine111/5/1
- 9.97Avapritinib如 Ayvakit113/6/1
- 9.98Pemigatinib如 Pemazyre113/6/1
- 9.99Gilteritinib如 Xospata115/8/1
- 9.100Acalabrutinib如 Calquence115/5/1
- 9.101Tepotinib如 Tepmetko113/6/1
- 9.102Dinutuximab beta如 Qarziba112/8/1
- 9.103Tisagenlecleucel如 Kymriah114/8/1
- 9.104Zanubrutinib如 Brukinsa115/5/1
- 9.105Polatuzumab vedotin如 Polivy114/8/1
- 9.106Sacituzumab govitecan如 Trodelvy114/10/1
- 9.107Abemaciclib如 Verzenio113/6/1
- 9.108Isatuximab如 Sarclisa114/9/1
- 9.109Enfortumab vedotin如 Padcev113/5/1
- 9.110Tirabrutinib如 Velexbru113/6/1
- 9.111Elotuzumab如 Empliciti113/9/1
- 9.112Pertuzumab與trastuzumab皮下注射複方製劑如 Phesgo114/5/1
- 9.113Gemtuzumab ozogamicin如 Mylotarg114/1/1
- 9.114Fedratinib如 Inrebic114/10/1
- 9.115Trastuzumab deruxtecan如 Enhertu114/2/1
- 9.116Selumetinib如 Koselugo114/2/1
- 9.117Selinexor如 Xpovio114/3/1
- 9.118Elranatamab如 Elrexfio114/8/1
- 9.119Teclistamab如 Tecvayli114/8/1
- 9.120Glofitamab如 Columvi114/8/1
- 9.121Epcoritamab如 Epkinly114/8/1
- 9.122Asciminib如 Scemblix114/9/1
- 9.123Ripretinib如 Qinlock114/9/1
- 9.124Tafasitamab如 Minjuvi115/4/1
- 9.125Quizartinib如 Vanflyta114/10/1
- 9.126Amivantamab如 Rybrevant114/10/1
- 9.127Momelotinib如 Omjjara114/10/1
- 9.128Tucidinostat如 Kepida114/12/1
- 9.129Alpelisib如 Piqray115/6/1
- 9.130Fulvestrant如 Fustron115/6/1
- 9.131Repotrectinib如 Augtyro115/2/1
- 9.132Bosutinib如 Bostini115/2/1
- 9.133Zolbetuximab如 Vyloy115/4/1
- 9.134Encorafenib如 Braftovi115/5/1
- 9.135Capivasertib如 Truqap115/6/1
- 9.136Fruquintinib如 Fruzaqla115/6/1
- 9.137Cabazitaxel如 Cabazred115/8/1
- 9.138Aumolertinib如 Pulmivex115/8/1